"Very Resistant to Variations" - Taylor Daily Press

Israel Tests Vaccine Oral.

The idea for a new oral vaccine was announced in March.

The vaccine is based on Oramat’s “POT” oral delivery technology and Premas vaccine technology.

The new oral Oravax vaccine targets the three structural proteins of the corona virus novel, as opposed to the single-spike protein targeted by current vaccines Modern e Pfizer.

The vaccine is being tested in preliminary studies against COVID-19 strains, including delta.

“An oral COVID-19 vaccine will remove many of the barriers to rapid and large-scale distribution so that people can take the vaccine at home,” Kidron told the Jerusalem Post.

“The simplicity of administration is needed today to speed up vaccination rates – he continued – the oral vaccine will become even more valuable if a Govt-19 vaccine is prescribed each year as a standard flu vaccine.” Oral vaccine is beyond safety and effective because oral medications “have fewer side effects” as indicated by Kitron.